Pulmonx Corp
For the period ended Jun 30, 2025. Filed Aug 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information
Insider Trading Arrangements
The following discussion includes trading arrangements adopted orterminated by our directors and officers during the three months ended June 30, 2025.
On May 19, 2025, Glendon French, a current member of ourboard of directors and former chief executive officer, adopted a new Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 340,000 shares of our common stock. The trading arrangement will expire on August 21, 2026, or earlier if all transactions under the trading arrangement are completed or if the trading arrangement is otherwise terminated according to its terms.
On June 13, 2025, Daniel Florin, a current member of ourboard of directors, adopted a new Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act for the sale of up to 23,321 shares of our common stock. The trading arrangement will expire on December 19, 2025, or earlier if all transactions under the trading arrangement are completed or if the trading arrangement is otherwise terminated according to its terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.